Urogen Pharma Ltdis A Biopharmaceutical Company Focused On Developing And Commercializing Innovative Solutions For Urothelial And Specialty Cancersfounded In 2004The Company Is Headquartered In Horshampennsylvaniawith Additional Operations In Tel Avivisraelurogen Pharma Is Dedicated To Enhancing Treatment Options For Patients With Urological Cancers Through Pioneering Therapies And Advanced Drug Delivery Systems The Company S Product Portfolio Includes Jelmytoan Approved Treatment For Low Grade Upper Tract Urothelial Cancerand Several Investigational Therapies Such As Ugn 102Ugn 301And Ugn 104Which Target Various Forms Of Bladder Cancerurogen Pharma Also Utilizes Its Rtgel Technology Platform To Improve The Effectiveness Of Drug Deliverythe Company Is Committed To Conducting Clinical Trials To Advance Its Pipeline And Provide Better Outcomes For Patients And Healthcare Providers
No conferences found for this company.
| Company Name | Urogene Sa |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
